These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 32645927)
1. Proteomics-Based Machine Learning Approach as an Alternative to Conventional Biomarkers for Differential Diagnosis of Chronic Kidney Diseases. Glazyrin YE; Veprintsev DV; Ler IA; Rossovskaya ML; Varygina SA; Glizer SL; Zamay TN; Petrova MM; Minic Z; Berezovski MV; Kichkailo AS Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645927 [TBL] [Abstract][Full Text] [Related]
2. Multisample Mass Spectrometry-Based Approach for Discovering Injury Markers in Chronic Kidney Disease. Kim JE; Han D; Jeong JS; Moon JJ; Moon HK; Lee S; Kim YC; Yoo KD; Lee JW; Kim DK; Kwon YJ; Kim YS; Yang SH Mol Cell Proteomics; 2021; 20():100037. PubMed ID: 33453410 [TBL] [Abstract][Full Text] [Related]
3. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease. Nkuipou-Kenfack E; Duranton F; Gayrard N; Argilés À; Lundin U; Weinberger KM; Dakna M; Delles C; Mullen W; Husi H; Klein J; Koeck T; Zürbig P; Mischak H PLoS One; 2014; 9(5):e96955. PubMed ID: 24817014 [TBL] [Abstract][Full Text] [Related]
6. Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures! Mischak H Nephrol Dial Transplant; 2015 Apr; 30(4):532-7. PubMed ID: 25801638 [TBL] [Abstract][Full Text] [Related]
7. Urinary Protein and Peptide Markers in Chronic Kidney Disease. Chebotareva N; Vinogradov A; McDonnell V; Zakharova NV; Indeykina MI; Moiseev S; Nikolaev EN; Kononikhin AS Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830001 [TBL] [Abstract][Full Text] [Related]
8. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention. Dubin RF; Rhee EP Clin J Am Soc Nephrol; 2020 Mar; 15(3):404-411. PubMed ID: 31636087 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of T-cell-mediated kidney rejection by biopsy-based proteomic biomarkers and machine learning. Fang F; Liu P; Song L; Wagner P; Bartlett D; Ma L; Li X; Rahimian MA; Tseng G; Randhawa P; Xiao K Front Immunol; 2023; 14():1090373. PubMed ID: 36814924 [TBL] [Abstract][Full Text] [Related]
10. Candidate protein biomarkers in chronic kidney disease: a proteomics study. Makhammajanov Z; Kabayeva A; Auganova D; Tarlykov P; Bukasov R; Turebekov D; Kanbay M; Molnar MZ; Kovesdy CP; Abidi SH; Gaipov A Sci Rep; 2024 Jun; 14(1):14014. PubMed ID: 38890379 [TBL] [Abstract][Full Text] [Related]
11. Applying proteomics to detect early signs of chronic kidney disease: where has the magic gone? Klein JB Expert Rev Proteomics; 2017 May; 14(5):387-390. PubMed ID: 28363249 [No Abstract] [Full Text] [Related]
12. CKD273, a new proteomics classifier assessing CKD and its prognosis. Argilés Á; Siwy J; Duranton F; Gayrard N; Dakna M; Lundin U; Osaba L; Delles C; Mourad G; Weinberger KM; Mischak H PLoS One; 2013; 8(5):e62837. PubMed ID: 23690958 [TBL] [Abstract][Full Text] [Related]
13. Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry. Smith A; Iablokov V; Mazza M; Guarnerio S; Denti V; Ivanova M; Stella M; Piga I; Chinello C; Heijs B; van Veelen PA; Benediktsson H; Muruve DA; Magni F Kidney Blood Press Res; 2020; 45(2):233-248. PubMed ID: 32062660 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Si S; Liu H; Xu L; Zhan S Genome Med; 2024 Jun; 16(1):84. PubMed ID: 38898508 [TBL] [Abstract][Full Text] [Related]
15. Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy. Papale M; Di Paolo S; Magistroni R; Lamacchia O; Di Palma AM; De Mattia A; Rocchetti MT; Furci L; Pasquali S; De Cosmo S; Cignarelli M; Gesualdo L Diabetes Care; 2010 Nov; 33(11):2409-15. PubMed ID: 20671095 [TBL] [Abstract][Full Text] [Related]
16. Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation. Milongo D; Bascands JL; Huart A; Esposito L; Breuil B; Moulos P; Siwy J; Ramírez-Torres A; Ribes D; Lavayssière L; Del Bello A; Muscari F; Alric L; Bureau C; Rostaing L; Schanstra JP; Kamar N Liver Int; 2015 Jul; 35(7):1893-901. PubMed ID: 25515948 [TBL] [Abstract][Full Text] [Related]
17. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression. Critselis E; Lambers Heerspink H Nephrol Dial Transplant; 2016 Feb; 31(2):249-54. PubMed ID: 25791724 [TBL] [Abstract][Full Text] [Related]
19. Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases. Filip S; Pontillo C; Peter Schanstra J; Vlahou A; Mischak H; Klein J Expert Rev Proteomics; 2014 Oct; 11(5):535-48. PubMed ID: 24957818 [TBL] [Abstract][Full Text] [Related]
20. Changes in urine proteome accompanying diabetic nephropathy progression. Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]